Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 contamination of high-touch surfaces in the public domain.
Hennessy NT, Toomey S, Gautier V, O'Reilly S, de Barra E, Hanrahan EO, Hennessy BT. Hennessy NT, et al. Among authors: hennessy bt. Ir J Med Sci. 2022 Dec;191(6):2839-2840. doi: 10.1007/s11845-021-02881-z. Epub 2022 Jan 10. Ir J Med Sci. 2022. PMID: 35001334 Free PMC article. No abstract available.
Non-Hodgkin lymphoma: an update.
Hennessy BT, Hanrahan EO, Daly PA. Hennessy BT, et al. Lancet Oncol. 2004 Jun;5(6):341-53. doi: 10.1016/S1470-2045(04)01490-1. Lancet Oncol. 2004. PMID: 15172354 Review.
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.
Abdul-Jalil KI, Sheehan KM, Toomey S, Schmid J, Prehn J, O'Grady A, Cummins R, O'Neill B, McNamara DA, Deasy J, Breathnach O, Grogan L, Rogers A, Doherty G, Winter D, Ryan J, El-Masry S, Gibbons D, Sheahan K, Gillen P, Kay EW, Hennessy BT. Abdul-Jalil KI, et al. Among authors: hennessy bt. Ann Surg Oncol. 2014 Aug;21(8):2642-9. doi: 10.1245/s10434-014-3658-x. Epub 2014 Apr 4. Ann Surg Oncol. 2014. PMID: 24700299
Immune effects of bevacizumab: killing two birds with one stone.
Elamin YY, Rafee S, Toomey S, Hennessy BT. Elamin YY, et al. Among authors: hennessy bt. Cancer Microenviron. 2015 Apr;8(1):15-21. doi: 10.1007/s12307-014-0160-8. Epub 2014 Oct 18. Cancer Microenviron. 2015. PMID: 25326055 Free PMC article.
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib.
Elster N, Cremona M, Morgan C, Toomey S, Carr A, O'Grady A, Hennessy BT, Eustace AJ. Elster N, et al. Among authors: hennessy bt. Breast Cancer Res Treat. 2015 Jan;149(2):373-83. doi: 10.1007/s10549-014-3239-5. Epub 2014 Dec 21. Breast Cancer Res Treat. 2015. PMID: 25528022
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
van den Hurk K, Balint B, Toomey S, O'Leary PC, Unwin L, Sheahan K, McDermott EW, Murphy I, van den Oord JJ, Rafferty M, FitzGerald DM, Moran J, Cummins R, MacEneaney O, Kay EW, O'Brien CP, Finn SP, Heffron CC, Murphy M, Yela R, Power DG, Regan PJ, McDermott CM, O'Keeffe A, Orosz Z, Donnellan PP, Crown JP, Hennessy BT, Gallagher WM. van den Hurk K, et al. Among authors: hennessy bt. Melanoma Res. 2015 Jun;25(3):189-99. doi: 10.1097/CMR.0000000000000149. Melanoma Res. 2015. PMID: 25746038
214 results